2Thomas ME,Morrison AR,Schreiner GF. Metabolic effects of fatty acid-bearing albumin on a proximal tubule cell line [ J ]. AJP - Renal Physiology,1995,268(6):1177 -1184.
1Moorhead JP, Chan MK, El - Nahas M, et al. Lipid nephrotoxicity in chronic progressive glomerular and tubulointerstitial disease. Lancet 1982;2:1309-1311.
2Hattori M, Nikotic-Paterson DJ, Miyazaki K, et al. Mechanisms of glomerular macrophage infiltration in lipid - induced renal injury. Kidney Int Suppl 1999;71:S47-S50.
3Maddox DA, Alavi FK, Santella RN, et al. Prevention of obesity - linked renal disease: agedependent effects of dietary food restriction. Kidney Int 2002;62:208-219.
5Sun L, Halaihel N, Zhang W, et al. Role of sterol regulatory element- binding protein 1 in regulation of renal lipid metabolism and glomerulosclerosis in diabetes mellitus. J Biol Chem 2002 ; 277 : 18919 - 18927.
6Sammuelsson O, Attman P, Knight - Gibson C, et al. Complex apolipoprotein B-containing lipoprotein particles are associated with a higher rate of progression of human chronic renal insufficiency. J Am Soc Nephrol 1998;9:1482-1488.
7Nosadini R, Tonolo G. Polyunsaturated fatty acids and renal fibrosis: pathophysiologic link and potential clinical implications. J Nephrol 2003 ; 16(Suppl 7) : S42- 47.
8Munmer P, Coresh J, Smith C, et al. Plasma lipids and risk of developing renal dysfunction :The Athemsclerosis Risk in Communities Study. Kidney Int 2000;58:293-301.
9Vaziri ND. Dyslipidemia of chronic renal failure: the nature, mechanisms, and potential consequences. Am J Renal Physiol 2006 ; 290 : F262 - F272.
